1. Benzodiazepines. (2022, September 1). Drug Enforcement Administration.
https://www.dea.gov/factsheets/benzodiazepines2. Kampman K. M. (2005). New medications for the treatment of cocaine dependence. Psychiatry (Edgmont (Pa. : Township)), 2(12), 44–48.
https://pubmed.ncbi.nlm.nih.gov/21120115/3. Kampman K. M. (2019). The treatment of cocaine use disorder. Science advances, 5(10), eaax1532.
https://doi.org/10.1126/sciadv.aax15324. Nestler E. J. (2005). The neurobiology of cocaine addiction. Science & practice perspectives, 3(1), 4–10.
https://doi.org/10.1151/spp053145. Roque Bravo, R., Faria, A. C., Brito-da-Costa, A. M., Carmo, H., Mladěnka, P., Dias da Silva, D., Remião, F., & On Behalf Of The Oemonom Researchers (2022). Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern. Toxins, 14(4), 278.
https://doi.org/10.3390/toxins140402786. Jamey J. Lister, Addie Weaver, Jennifer D. Ellis, Joseph A. Himle & David M. Ledgerwood (2020) A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States, The American Journal of Drug and Alcohol Abuse, 46:3, 273-288, DOI: 10.1080/00952990.2019.1694536
7. Schwartz, B. G., Rezkalla, S., & Kloner, R. A. (2010). Cardiovascular effects of cocaine. Circulation, 122(24), 2558–2569.
https://doi.org/10.1161/CIRCULATIONAHA.110.940569